Document is current
Any future updates will be listed below
-
Authors
Malhotra, Jyoti
Kim, Edward S.
- License Information
-
More Information
Article History
Accepted: 16 September 2022
First Online: 28 November 2022
Declarations
:
: Jyoti Malhotra has served on the advisory board for Astra-Zeneca, Blueprint Medicines, Mirati Therapeutics, Sanofi, Oncocyte, and Beigene and received research funding from Bristol-Myers Squibb, Celldex, Biohaven, Daiichi Sankyo, and Beyond Spring Pharmaceuticals. Edward Kim has received personal fees from AstraZeneca and Genentech.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
